![]() ![]() MCI MoCA dementia diagnosis memory clinic s-MoCA. In conclusion, in these pragmatic diagnostic test accuracy studies, s-MoCA proved acceptable and sensitive for the diagnosis of cognitive impairment in a memory clinic setting, with a performance similar to that of the original MoCA. Using the cut-off for s-MoCA specified in the index study, it proved highly sensitive (>0.9) for diagnosis of dementia but with poor specificity (≤0.25), with moderate sensitivity (≥0.75) and specificity (≥0.60) for diagnosis of MCI. 01), and s-MoCA effect sizes (Cohen d) were medium to large (range: 0.65-1.42) for the diagnosis of dementia and MCI. There were significant differences in s-MoCA test scores for dementia, MCI, and subjective memory impairment ( P ≤. Diagnosis used standard clinical diagnostic criteria for dementia and MCI as reference standard (prevalence of cognitive impairment = 0.43 and 0.46 in each cohort, respectively). doi:10.1371/ diagnostic accuracy of the short Montreal Cognitive Assessment (s-MoCA), a cognitive screening instrument recently derived by item response theory and computerized adaptive testing from the original MoCA, for the diagnosis of dementia and mild cognitive impairment (MCI) was assessed in 2 patient cohorts referred to a dedicated memory clinic in order to examine the validity and reproducibility of s-MoCA. Pneumonia-associated death in patients with dementia: a systematic review and meta-analysis. The Montreal Cognitive Assessment (MoCA): Validation of alternate. Manabe T, Fujikura Y, Mizukami K, Akatsu H, Kudo K. Chertkow, H., Nasreddine, Z., Phillips, N., Johns, E., Whitehead, V., McHenry, C. Staffaroni A, Elahi F, McDermott D, et al. Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma. Kim K, Kim M-J, Kim DW, Kim SY, Park S, Park CB. We compared MoCA and MMSE total scores and the number of. This study examined its usefulness for assessing cognitive performance in mild, moderate, and severe Huntington’s disease (HD), as compared to the MMSE. Increasing precision of clinical diagnosis of Alzheimer's disease using a combined algorithm incorporating clinical and novel biomarker data. The Montreal Cognitive Assessment (MoCA) is a brief screening instrument for dementia that is sensitive to executive dysfunction. Alzheimer’s disease: rapid and slow progression. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features. Garn H, Coronel C, Waser M, Caravias G, Ransmayr G. Alzheimer's disease: diagnosis and treatment across the spectrum of disease severity. Current understanding of Alzheimer's disease diagnosis and treatment. Digitally translated Self-Administered Gerocognitive Examination (eSAGE): relationship with its validated paper version, neuropsychological evaluations, and clinical assessments. Scharre DW, Chang SI, Nagaraja HN, Vrettos NE, Bornstein RA.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |